Am J Psychiatry 159:1927-1929, November 2002
© 2002 American Psychiatric Association
Self-Reported Adherence to Treatment With Mood Stabilizers, Plasma Levels, and Psychiatric Hospitalization
Jan Scott, M.D., F.R.C.Psych., and
Marie Pope, M.Sc.
OBJECTIVE: The authors explored the relationship of adherence to treatment with mood stabilizers (lithium, carbamazepine, and sodium valproate) and plasma levels of these drugs to future psychiatric hospitalizations. METHOD: They prospectively followed 98 patients with mood disorders who were prescribed mood stabilizers. These patients participated in an initial interview and completed a questionnaire regarding their adherence to the medications. Data on their plasma levels of these drugs were taken from assays done in the 3 months before the interview. RESULTS: Six of the 98 patients were not classified as to medication adherence or plasma levels. Twenty-nine (32%) of the remaining patients reported partial adherence to the medication regimen, and 33 (36%) had an index plasma level that was suboptimal. At 18 months, rates of admission to a psychiatric hospital were significantly higher in the 16 partially adherent patients with subtherapeutic plasma levels (N=13, 81%) than in the 46 adherent patients with therapeutic plasma levels (N=4, 9%). However, hospital admission was also more likely in partially adherent patients with therapeutic plasma levels than in adherent patients with subtherapeutic plasma levels. CONCLUSIONS: Adherence to medication regimens may be a proxy measure of other healthy behaviors.
This article has been cited by other articles:
|
|
|
|
 
M. Hassan and M. J. Lage
Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge
Am. J. Health Syst. Pharm.,
February 15, 2009;
66(4):
358 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Prince, A. Akincigil, D. R. Hoover, J. T. Walkup, S. Bilder, and S. Crystal
Substance Abuse and Hospitalization for Mood Disorder Among Medicaid Beneficiaries
Am J Public Health,
January 1, 2009;
99(1):
160 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Gaudiano, L. M. Weinstock, and I. W. Miller
Improving Treatment Adherence in Bipolar Disorder: A Review of Current Psychosocial Treatment Efficacy and Recommendations for Future Treatment Development
Behav Modif,
May 1, 2008;
32(3):
267 - 301.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Hassan, S S. Madhavan, I. D Kalsekar, E. H Makela, K. Rajagopalan, S. Islam, J. Kavookjian, and L.-A. Miller
Comparing Adherence to and Persistence with Antipsychotic Therapy Among Patients with Bipolar Disorder
Ann. Pharmacother.,
November 1, 2007;
41(11):
1812 - 1818.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Mitchell and T. Selmes
Why don't patients take their medicine? Reasons and solutions in psychiatry
Advan. Psychiatr. Treat.,
September 1, 2007;
13(5):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Scott
Psychotherapy for bipolar disorders - efficacy and effectiveness
J Psychopharmacol,
March 1, 2006;
20(2_suppl):
46 - 50.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Sajatovic, M. Davies, and D. R. Hrouda
Enhancement of Treatment Adherence Among Patients With Bipolar Disorder
Psychiatr Serv,
March 1, 2004;
55(3):
264 - 269.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
